Year in review 2017: Chronic obstructive pulmonary disease and asthma

Respirology

Volumn 23, Issue 5, 2018, Pages 538-545

  Benton, Melissa J ^a   Lim, Tow Keang ^b   Ko, Fanny W S ^c   Kan o, Keiko ^d   Mak, Judith C W ^e  

^a UNIVERSITY OF COLORADO   (United States)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d KYUSHU UNIVERSITY   (Japan)

^e UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

asthma; chronic obstructive pulmonary disease; genetics; respiratory hypersensitivity

Indexed keywords

BRONCHODILATING AGENT; CIGARETTE SMOKE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC OXIDE; PROBIOTIC AGENT;

ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; COMORBIDITY; DISEASE COURSE; DISEASE EXACERBATION; DNA METHYLATION; EXERCISE; FRACTIONAL EXHALED NITRIC OXIDE; HEALTH CARE COST; HUMAN; HYPOXEMIA; LUNG FUNCTION; MICROFLORA; NONHUMAN; PATHOGENESIS; PHARMACOLOGICAL PROCEDURES; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULMONARY REHABILITATION; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFLAMMATION; REVIEW; RISK FACTOR; SMOKING;

EID: 85043277379     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.13285     Document Type: Review

References (81)

1. World Health Organization. Chronic respiratory diseases. [Accessed 12 Feb 2018.] Available from URL: http://www.who.int/respiratory/en/
2. GBD 2015 Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir. Med. 2017; 5: 691–706.
3. Numata T, Nakayama K, Fujii S, Yumino Y, Saito N, Yoshida M, Kurita Y, Kobayashi K, Ito S, Utsumi H et al. Risk factors of postoperative pulmonary complications in patients with asthma and COPD. BMC Pulm. Med. 2018; 18: 4.
4. Shin B, Lee H, Kang D, Jeong BH, Kang HK, Chon HR, Koh WJ, Chung MP, Guallar E, Cho J et al. Airflow limitation severity and post-operative pulmonary complications following extra-pulmonary surgery in COPD patients. Respirology 2017; 22: 935–41.
5. Alison JA, McKeough ZJ, Johnston K, McNamara RJ, Spencer LM, Jenkins SC, Hill CJ, McDonald VM, Frith P, Cafarella P et al. Australian and New Zealand pulmonary rehabilitation guidelines. Respirology 2017; 22: 800–19.
6. Tsai LL, McNamara RJ, Moddel C, Alison JA, McKenzie DK, McKeough ZJ. Home-based telerehabilitation via real-time videoconferencing improves endurance exercise capacity in patients with COPD: the randomized controlled TeleR Study. Respirology 2017; 22: 699–707.
7. Ponte EV, Lima A, Almeida PCA, de Jesus JPV, Lima VB, Scichilone N, Souza-Machado A, Cruz AA. Age is associated with asthma phenotypes. Respirology 2017; 22: 1558–63.
8. McGeachie MJ, Yates KP, Zhou X, Guo F, Sternberg AL, Van Natta ML, Wise RA, Szefler SJ, Sharma S, Kho AT et al. Patterns of growth and decline in lung function in persistent childhood asthma. N. Engl. J. Med. 2016; 374: 1842–52.
9. Owens L, Laing IA, Zhang G, Le Souef PN. Infant lung function predicts asthma persistence and remission in young adults. Respirology 2017; 22: 289–94.
10. Juan Z, Zhao-Ling S, Ming-Hua Z, Chun W, Hai-Xia W, Meng-Yun L, Jian-Qiong H, Yue-Jie Z, Xin S. Oral administration of Clostridium butyricum CGMCC0313-1 reduces ovalbumin-induced allergic airway inflammation in mice. Respirology 2017; 22: 898–904.
11. Fonseca VMB, Milani TMS, Prado R, Bonato VLD, Ramos SG, Martins FS, Vianna EO, Borges MC. Oral administration of Saccharomyces cerevisiae UFMG A-905 prevents allergic asthma in mice. Respirology 2017; 22: 905–12.
12. Elazab N, Mendy A, Gasana J, Vieira ER, Quizon A, Forno E. Probiotic administration in early life, atopy, and asthma: a meta-analysis of clinical trials. Pediatrics 2013; 132: e666–76.
13. Azad MB, Coneys JG, Kozyrskyj AL, Field CJ, Ramsey CD, Becker AB, Friesen C, Abou-Setta AM, Zarychanski R. Probiotic supplementation during pregnancy or infancy for the prevention of asthma and wheeze: systematic review and meta-analysis. BMJ 2013; 347: f6471.
14. Reddel HK, Beckert L, Moran A, Ingham T, Ampon RD, Peters MJ, Sawyer SM. Is higher population-level use of ICS/LABA combination associated with better asthma outcomes? Cross-sectional surveys of nationally representative populations in New Zealand and Australia. Respirology 2017; 22: 1570–8.
15. World Health Organization. Bronchial asthma. [Accessed 12 Feb 2018.] Available from URL: http://www.who.int/mediacentre/factsheets/fs206/en/
16. Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM et al. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary. Respirology 2017; 22: 575–601.
17. Nishimura M. Lessons for COPD from the GOLD 2017 report. Respirology 2017; 22: 621.
18. Jones B, Donovan C, Liu G, Gomez HM, Chimankar V, Harrison CL, Wiegman CH, Adcock IM, Knight DA, Hirota JA et al. Animal models of COPD: what do they tell us? Respirology 2017; 22: 21–32.
19. Sin DD, King GG. COPD: lessons learned, forging a fantastic future. Respirology 2017; 22: 632–3.
20. de Jong PA, Mohamed Hoesein F. Precision medicine in COPD: are we making it too difficult? Respirology 2017; 22: 211–2.
21. Eapen MS, McAlinden K, Tan D, Weston S, Ward C, Muller HK, Walters EH, Sohal SS. Profiling cellular and inflammatory changes in the airway wall of mild to moderate COPD. Respirology 2017; 22: 1125–32.
22. Leung JM, Tiew PY, Mac Aogain M, Budden KF, Yong VF, Thomas SS, Pethe K, Hansbro PM, Chotirmall SH. The role of acute and chronic respiratory colonization and infections in the pathogenesis of COPD. Respirology 2017; 22: 634–50.
23. Qiu F, Li Y, Lu X, Xie C, Nong Q, Wu D, Chen J, Yang L, Zhou Y, Lu J. Rare variant of MAP2K7 is associated with increased risk of COPD in southern and eastern Chinese. Respirology 2017; 22: 691–8.
24. Barnawi J, Jersmann H, Haberberger R, Hodge S, Meech R. Reduced DNA methylation of sphingosine-1 phosphate receptor 5 in alveolar macrophages in COPD: a potential link to failed efferocytosis. Respirology 2017; 22: 315–21.
25. Mahmood MQ, Reid D, Ward C, Muller HK, Knight DA, Sohal SS, Walters EH. Transforming growth factor (TGF) beta1 and Smad signalling pathways: a likely key to EMT-associated COPD pathogenesis. Respirology 2017; 22: 133–40.
26. Lee KY, Park SY, Park S, Hong GH, Moon KA, Kim YS, Oh YM, Kwon HS, Kim TB, Moon HB et al. Progranulin protects lung epithelial cells from cigarette smoking-induced apoptosis. Respirology 2017; 22: 1140–8.
27. Pouwels SD, van Geffen WH, Jonker MR, Kerstjens HA, Nawijn MC, Heijink IH. Increased neutrophil expression of pattern recognition receptors during COPD exacerbations. Respirology 2017; 22: 401–4.
28. Ishii T, Angata T, Wan ES, Cho MH, Motegi T, Gao C, Ohtsubo K, Kitazume S, Gemma A, Par EP et al. Influence of SIGLEC9 polymorphisms on COPD phenotypes including exacerbation frequency. Respirology 2017; 22: 684–90.
29. Hu X, Sun Y, Xu W, Lin T, Zeng H. Expression of RANKL by peripheral neutrophils and its association with bone mineral density in COPD. Respirology 2017; 22: 126–32.
30. Chen WC, Huang CH, Sheu CC, Chong IW, Chu KA, Chen YC, Tsai JR, Lee CH, Wei YF. Long-acting beta2-agonists versus long-acting muscarinic antagonists in patients with stable COPD: a systematic review and meta-analysis of randomized controlled trials. Respirology 2017; 22: 1313–9.
31. Calverley PMA. Where to start when treating COPD? Respirology 2017; 22: 1239–40.
32. Raymakers AJ, McCormick N, Marra CA, Fitzgerald JM, Sin D, Lynd LD. Do inhaled corticosteroids protect against lung cancer in patients with COPD? A systematic review. Respirology 2017; 22: 61–70.
33. Zhou S, Xiao D, Peng P, Wang SK, Liu Z, Qin HY, Li SS, Wang C. Effect of smoking on resting-state functional connectivity in smokers: an fMRI study. Respirology 2017; 22: 1118–24.
34. Pilcher J, Eastlake L, Richards M, Power S, Cripps T, Bibby S, Braithwaite I, Weatherall M, Beasley R. Physiological effects of titrated oxygen via nasal high-flow cannulae in COPD exacerbations: a randomized controlled cross-over trial. Respirology 2017; 22: 1149–55.
35. Braunlich J, Wirtz H. NHF and hypercapnia: how brief can you look? Respirology 2017; 22: 1049–50.
36. Schwarz SB, Windisch W, Magnet FS, Schmoor C, Karagiannidis C, Callegari J, Huttmann SE, Storre JH. Continuous non-invasive PCO2 monitoring in weaning patients: transcutaneous is advantageous over end-tidal PCO2. Respirology 2017; 22: 1579–84.
37. Antenora F, Fantini R, Iattoni A, Castaniere I, Sdanganelli A, Livrieri F, Tonelli R, Zona S, Monelli M, Clini EM et al. Prevalence and outcomes of diaphragmatic dysfunction assessed by ultrasound technology during acute exacerbation of COPD: a pilot study. Respirology 2017; 22: 338–44.
38. Okura K, Kawagoshi A, Iwakura M, Sugawara K, Takahashi H, Kashiwagura T, Homma M, Satake M, Shioya T. Contractile capability of the diaphragm assessed by ultrasonography predicts nocturnal oxygen saturation in COPD. Respirology 2017; 22: 301–6.
39. Lopez-Campos JL, Caballero-Eraso C, Barrot-Cortes E. Home mechanical ventilation for stable COPD in GOLD 2017: what are we ventilating? Respirology 2017; 22: 1497–9.
40. Franssen FM, Spruit MA. Pulmonary rehabilitation in Australia and New Zealand: from guidelines to personalized treatment. Respirology 2017; 22: 622–3.
41. Clarenbach CF, Sievi NA, Haile SR, Brack T, Brutsche MH, Frey M, Irani S, Leuppi JD, Thurnheer R, Kohler M. Determinants of annual change in physical activity in COPD. Respirology 2017; 22: 1133–9.
42. Braeken DCW, Spruit MA, Houben-Wilke S, Smid DE, Rohde GGU, Wouters EFM, Franssen FME. Impact of exacerbations on adherence and outcomes of pulmonary rehabilitation in patients with COPD. Respirology 2017; 22: 942–9.
43. Holland AE, Cox NS. Telerehabilitation for COPD: could pulmonary rehabilitation deliver on its promise? Respirology 2017; 22: 626–7.
44. Robles P, Araujo T, Brooks D, Zabjek K, Janaudis-Ferreira T, Marzolini S, Goldstein R, Mathur S. Does limb partitioning and positioning affect acute cardiorespiratory responses during strength exercises in patients with COPD? Respirology 2017; 22: 1336–42.
45. Vaes AW. Partitioning strength exercises as an alternative training modality for patients with COPD. Respirology 2017; 22: 1243–4.
46. Al-Kassimi FA, Alhamad EH, Al-Hajjaj MS, Raddaoui E, Alzeer AH, Alboukai AA, Somily AM, Cal JG, Ibrahim AF, Shaik SA. Can computed tomography and carbon monoxide transfer coefficient diagnose an asthma-like phenotype in COPD? Respirology 2017; 22: 322–8.
47. Houben-Wilke S, Spruit MA, Uszko-Lencer N, Otkinska G, Vanfleteren L, Jones PW, Wouters EFM, Franssen FME. Echocardiographic abnormalities and their impact on health status in patients with COPD referred for pulmonary rehabilitation. Respirology 2017; 22: 928–34.
48. Nakahara Y, Taniguchi H, Kimura T, Kondoh Y, Arizono S, Nishimura K, Sakamoto K, Ito S, Ando M, Hasegawa Y. Exercise hypoxaemia as a predictor of pulmonary hypertension in COPD patients without severe resting hypoxaemia. Respirology 2017; 22: 120–5.
49. Zhou Z, Zhou A, Zhao Y, Chen P. Evaluating the Clinical COPD Questionnaire: a systematic review. Respirology 2017; 22: 251–62.
50. Chan HP, Mukhopadhyay A, Chong PL, Chin S, Wong XY, Ong V, Chan YH, Lim TK, Phua J. Role of BMI, airflow obstruction, St George's Respiratory Questionnaire and age index in prognostication of Asian COPD. Respirology 2017; 22: 114–9.
51. Nakken N, Janssen DJ, van den Bogaart EH, van Vliet M, de Vries GJ, Bootsma GP, Gronenschild MH, Delbressine JM, Muris JW, Wouters EF et al. Patient versus proxy-reported problematic activities of daily life in patients with COPD. Respirology 2017; 22: 307–14.
52. Ebmeier S, Thayabaran D, Braithwaite I, Benamara C, Weatherall M, Beasley R. Trends in international asthma mortality: analysis of data from the WHO Mortality Database from 46 countries (1993-2012). Lancet 2017; 390: 935–45.
53. Bush A, Fleming L, Saglani S. Severe asthma in children. Respirology 2017; 22: 886–97.
54. Fricker M, Heaney LG, Upham JW. Can biomarkers help us hit targets in difficult-to-treat asthma? Respirology 2017; 22: 430–42.
55. McDonald VM, Maltby S, Reddel HK, King GG, Wark PA, Smith L, Upham JW, James AL, Marks GB, Gibson PG. Severe asthma: current management, targeted therapies and future directions-a roundtable report. Respirology 2017; 22: 53–60.
56. Porsbjerg C, Menzies-Gow A. Co-morbidities in severe asthma: clinical impact and management. Respirology 2017; 22: 651–61.
57. Clark VL, Gibson PG, Genn G, Hiles SA, Pavord ID, McDonald VM. Multidimensional assessment of severe asthma: a systematic review and meta-analysis. Respirology 2017; 22: 1262–75.
58. Visitsunthorn N, Mahawichit N, Maneechotesuwan K. Association between levels of fractional exhaled nitric oxide and asthma exacerbations in Thai children. Respirology 2017; 22: 71–7.
59. Kim JK, Jung JY, Kim H, Eom SY, Hahn YS. Combined use of fractional exhaled nitric oxide and bronchodilator response in predicting future loss of asthma control among children with atopic asthma. Respirology 2017; 22: 466–72.
60. Matsunaga NY, Oliveira MS, Morcillo AM, Ribeiro JD, Ribeiro M, Toro A. Physical activity and asthma control level in children and adolescents. Respirology 2017; 22: 1643–8.
61. Habukawa C, Murakami K, Endoh M, Horii N, Nagasaka Y. Treatment evaluation using lung sound analysis in asthmatic children. Respirology 2017; 22: 1564–9.
62. Balakrishnan L, Rennie D, Dosman J, Pahwa P, Karunanayake C, Hagel L, Lawson J. Lung function in relation to farm dwelling and farming activities in rural dwelling children. Respirology 2017; 22: 1320–8.
63. Movin M, Garden FL, Protudjer JL, Ullemar V, Svensdotter F, Andersson D, Kruse A, Cowell CT, Toelle BG, Marks GB et al. Impact of childhood asthma on growth trajectories in early adolescence: findings from the Childhood Asthma Prevention Study (CAPS). Respirology 2017; 22: 460–5.
64. Moore WC, Fitzpatrick AM, Li X, Hastie AT, Li H, Meyers DA, Bleecker ER. Clinical heterogeneity in the severe asthma research program. Ann. Am. Thorac. Soc. 2013; 10(Suppl.): S118–24.
65. de Farias CF, Amorim MM, Dracoulakis M, Caetano LB, Santoro IL, Fernandes AL. Nasal lavage, blood or sputum: which is best for phenotyping asthma? Respirology 2017; 22: 671–7.
66. Bjerregaard A, Laing IA, Backer V, Fally M, Khoo SK, Chidlow G, Sikazwe C, Smith DW, Le Souef P, Porsbjerg C. Clinical characteristics of eosinophilic asthma exacerbations. Respirology 2017; 22: 295–300.
67. White EC, de Klerk N, Hantos Z, Priston M, Hollams EM, James A, Sly PD, Holt PG, Hall GL. Mannitol challenge testing for asthma in a community cohort of young adults. Respirology 2017; 22: 678–83.
68. Musa BM, Galadanci NA, Rodeghier M, Debaun MR. Higher prevalence of wheezing and lower FEV1 and FVC percent predicted in adults with sickle cell anaemia: a cross-sectional study. Respirology 2017; 22: 284–8.
69. Papaporfyriou A, Bakakos P, Kostikas K, Papatheodorou G, Hillas G, Trigidou R, Katafigiotis P, Koulouris NG, Papiris SA, Loukides S. Activin A and follistatin in patients with asthma. Does severity make the difference? Respirology 2017; 22: 473–9.
70. Robinson PD, King GG, Sears MR, Hong CY, Hancox RJ. Determinants of peripheral airway function in adults with and without asthma. Respirology 2017; 22: 1110–7.
71. GINA Report2017, Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma. [Accessed 30 Dec 2017.] Available from URL: http://ginasthma.org/2017-gina-report-global-strategy-for-asthma-management-and-prevention/
72. Tai A, Tran H, Roberts M, Clarke N, Gibson AM, Vidmar S, Wilson J, Robertson CF. Outcomes of childhood asthma to the age of 50 years. J. Allergy Clin. Immunol. 2014; 133: 1572–8.e3.
73. Omori K, Iwamoto H, Yamane T, Nakashima T, Haruta Y, Hattori N, Yokoyama A, Kohno N. Clinically remitted childhood asthma is associated with airflow obstruction in middle-aged adults. Respirology 2017; 22: 86–92.
74. Nguyen HV, Nadkarni NV, Sankari U, Mital S, Lye WK, Tan NC. Association between asthma control and asthma cost: results from a longitudinal study in a primary care setting. Respirology 2017; 22: 454–9.
75. Nguyen HV, Bose S, Mital S, Yii ACA, Ang SY, Lam SSW, Anantham D, Finkelstein E, Koh MS. Is bronchial thermoplasty cost-effective as treatment for problematic asthma patients? Singapore's perspective on a global model. Respirology 2017; 22: 1102–9.
76. Maltby S, Tay HL, Yang M, Foster PS. Mouse models of severe asthma: understanding the mechanisms of steroid resistance, tissue remodelling and disease exacerbation. Respirology 2017; 22: 874–85.
77. Wang KCW, Morton JS, Davidge ST, Larcombe AN, James AL, Donovan GM, Noble PB. Increased heterogeneity of airway calibre in adult rats after hypoxia-induced intrauterine growth restriction. Respirology 2017; 22: 1329–35.
78. Wang KCW, Larcombe AN, Berry LJ, Morton JS, Davidge ST, James AL, Noble PB. Fetal growth restriction in mice modifies postnatal airway responsiveness in an age and sex-dependent manner. Clin. Sci. (Lond.) 2018; 132: 273–84.
79. Huang P, Li Y, Lv Z, Wang J, Zhang Q, Yao X, Corrigan CJ, Huang K, Wang W, Ying S. Comprehensive attenuation of IL-25-induced airway hyperresponsiveness, inflammation and remodelling by the PI3K inhibitor LY294002. Respirology 2017; 22: 78–85.
80. Gu W, Cui R, Ding T, Li X, Peng J, Xu W, Han F, Guo X. Simvastatin alleviates airway inflammation and remodelling through up-regulation of autophagy in mouse models of asthma. Respirology 2017; 22: 533–41.
81. Suzaki I, Kawano S, Komiya K, Tanabe T, Akaba T, Asano K, Suzaki H, Izuhara K, Rubin BK. Inhibition of IL-13-induced periostin in airway epithelium attenuates cellular protein expression of MUC5AC. Respirology 2017; 22: 93–100.